Articles tagged with Cancer Patients
A national study has found that the majority of kidney cancers are now diagnosed at an earlier stage, with a significant increase in stage I tumors and improved overall survival rates. The study attributes this trend to the increased use of medical imaging, which leads to the detection of smaller, non-symptomatic tumors.
Researchers have developed a novel method to expand natural killer cells from umbilical cord blood, effectively killing human leukemia cells in mice. The treatment demonstrates significant cytotoxic activity against both acute lymphocytic leukemia (ALL) and acute myelogenous leukemia (AML).
A Phase III clinical trial found that everolimus significantly delays cancer progression in patients with metastatic kidney cancer. The study showed a 26% reduction in disease progression after six months compared to the placebo group.
A new study suggests that the depth of cancer penetration in the bowel wall affects survival rates, and proposes changes to current guidelines. Patients with thin lesions confined to the bowel wall have better survival outcomes than those with thicker cancers.
CAPHOSOL, an advanced electrolyte solution, has been shown to relieve oral mucositis and improve quality of life for cancer patients. The study found that 95% of patients reported favorable OM scores and high levels of patient and practitioner satisfaction with CAPHOSOL.
Researchers discovered a drug combination that inhibits glycolysis and intensifies cellular starvation, resulting in over 90% cell death in human tissue cultures of acute lymphocytic leukemia. The novel approach offers a promising alternative to current treatments.
The Professional Action Coordinating Teams (PACTs) at M. D. Anderson Cancer Center have seen a significant increase in participation among nurses, with a 50% growth in one year. This growth is attributed to the short commitment of time, decisive action, and leadership opportunities provided by PACTs.
Researchers identified three primary themes of fatigue in cancer patients undergoing standard radiation therapy: loss of strength, major effects on energy levels, and physical sensations. The study aims to develop a single definition of cancer-related fatigue, enabling healthcare professionals to intervene more effectively with patients.
Childhood cancer survivors who received cyclophosphamide chemotherapy are at a higher risk of developing bladder cancer. Researchers found that the risk increases over time, with a significant increase after 20 years post-treatment.
Researchers at University of Texas M. D. Anderson Cancer Center found a combination therapy approach that makes cancer cells more sensitive to immune system cells and strengthens the power of these cells, potentially sparing young patients from difficult treatments.
Researchers at Georgetown University Medical Center have developed a blood test that can predict treatment efficacy in metastatic breast cancer patients. The test measures circulating tumor cells and has been shown to be a reliable predictor of disease progression.
A rare case of extrahepatic bile duct cancer producing granulocyte colony-stimulating factor (G-CSF) has been reported, highlighting the need for early diagnosis and treatment. The discovery raises concerns about the potential impact on prognosis and treatment options.
Women with a sister diagnosed with breast cancer face an increased risk of developing the disease throughout their lives. Regular exercise during adolescence and young adulthood is associated with a lower risk of premenopausal breast cancer. Meanwhile, disparities in rectal cancer outcomes persist despite access to oncologists, highlig...
A new study from the University of Michigan Comprehensive Cancer Center found that black patients are 23% less likely to receive chemotherapy and 12% less likely to receive radiation therapy for rectal cancer compared to white patients. Despite similar rates of consultation with oncologists, disparities in treatment initiation persist.
Researchers at U-M Comprehensive Cancer Center found that HPV-positive tumors are more responsive to chemotherapy and radiation treatments. The study also identified biomarkers that can determine which patients are most likely to survive and thrive with tailored treatment plans.
Researchers at MGH have developed a new laser treatment that targets blood vessels to remove tumors while preserving and restoring vocal quality. Over 25 patients have been treated, with all being cancer-free up to 5 years after treatment.
Breast cancer patients with a history of mood and anxiety disorders are more likely to develop posttraumatic stress disorder (PTSD) after diagnosis. The study found that 16% of breast cancer patients developed PTSD within 18 months of diagnosis, with women having previous mood disorders being over twice as likely to develop the condition.
Researchers found that heart failure patients with poor health status have higher symptom burden, depression, and lower spiritual well-being than cancer patients. Palliative care is underused in heart failure patients, but identifying those who may benefit from it, such as those with low health status scores, can improve quality of life.
Researchers found a link between PTOV1 gene expression and prostate cancer development in HG-PIN lesions. The study suggests using the biomarker to determine which men with HG-PIN are at substantial risk of developing prostate cancer, potentially saving up to 40% of unnecessary biopsies.
Researchers have found a biomarker that can distinguish between HG-PIN lesions destined to become cancerous and those that will remain benign. The PTOV1 gene marker is linked to prostate cancer development and can help determine which men with HG-PIN are at substantial risk of developing prostate cancer.
Researchers measured breast cancer patients' upper limb volume before and after surgery to establish a baseline and monitor for lymphedema. The study found that early detection using compression garments effectively treated subclinical lymphedema.
A new study published in the Journal of the National Cancer Institute estimates that Medicare costs for elderly cancer patients will top $21.1 billion over a 5-year period. The estimated cost varies widely depending on tumor type, stage at diagnosis, and phase of care.
Cancer rates are on the rise in Albania, driven by changing lifestyles and limited healthcare resources. The country is seeking international support to tackle the crisis, with organizations like IAEA working to improve cancer control and palliative care.
A study published in JAMA found that cisplatin is not an effective alternative to standard treatment for anal cancer, with a lower disease-free survival rate and more colostomies. The research suggests that fluorouracil plus mitomycin and radiotherapy remains the best treatment option for patients with anal canal cancer.
A randomized controlled trial found that chemotherapy with cisplatin before concurrent chemoradiation did not improve disease-free survival for patients with anal canal cancer. The therapy resulted in a higher rate of colostomy procedures and was associated with severe hematologic toxicity.
Stored ovarian tissue from cancer patients may contain residual cancer cells that can re-infect the body if not checked. Research suggests that few fertility centers have the skills and technology to detect these cells, highlighting the need for improved testing methods.
A recent study published in the journal Cancer found that nearly half of Canadian cancer survivors were overweight or obese, comparable to the general population. The research highlights the importance of promoting physical activity and healthy eating habits among cancer patients to prevent recurrence and improve overall health.
Researchers detail chemotherapy's damage to the brain, finding that healthy cells die off long after treatment ends. The study identifies 5-fluorouracil as a contributor to chemo brain, with damaged oligodendrocytes leading to cognitive decline and demyelination.
A new study reveals that cancer survivors in Canada have low levels of physical activity and high prevalence of obesity. The findings suggest that lifestyle interventions to promote physical activity and healthy weight management are necessary among cancer survivors to control their disease.
A study found that follow-up care for breast cancer patients costs less when led by nurses rather than physicians, with significant savings potential for healthcare budgets. Specialist nurse-led follow-up resulted in €866 per patient over a five-year period, making it a cost-effective alternative.
Researchers found that common versions of FGFR2 and TNRC9 genes increase breast cancer risk in women carrying damaged BRCA2 gene. The study suggests that knowledge of a BRCA mutation is necessary but not sufficient to fully understand cancer risk.
OHSU Cancer Institute researchers discovered the gene ASPP2 is necessary in eliminating cancer cells. This protein activates pathways that tell cancer cells to die, protecting them from one of the steps leading to cancer. The study may lead to better therapies and cancer care for patients.
Researchers have developed tests that diagnose, predict or monitor cancer risks without invasive tissue sampling. Oral epithelium can be used as a surrogate tissue to assess molecular damage to the lungs, allowing for convenient biomonitoring methods.
Researchers found that lung cancer patients over 80 fare equally well after surgery as their younger counterparts, while elevated interleukin-12 levels are associated with poorer survival rates in melanoma patients. DNA methylation decreases with age, potentially contributing to cancer development.
Researchers are using cellular strategies and new vaccines to direct the body's immune system against cancer. A phase I/II trial of a live Listeria cancer vaccine has shown that it is safe for humans and can reduce tumor size in some patients, with three women experiencing approximately 20 percent tumor reductions.
Researchers present promising results for new therapies targeting VEGF receptors and blood vessel formation in various types of cancer. These treatments have shown potential to shrink tumors and prolong survival for patients with glioblastoma and rectal cancer.
A study from Georgetown University Medical Center suggests that high-energy space radiation can lead to premature aging and prolonged oxidative stress in cells, potentially causing colon cancer. The researchers found that exposure to high-LET radiation induced a highly oxidative environment in cells, conducive to cancer development.
Researchers found that sunitinib treatment slowed tumor growth and reduced the risk of metastasis in patients with advanced hepatocellular carcinoma. The median progression-free survival was four months, and the median overall survival was 10 months.
Researchers found that combining low-dose DFMO with sulindac reduced recurrent colorectal adenoma risk by up to 95% without significant toxicity. The combination therapy also showed significant reductions in advanced adenoma recurrence rates, including a 92% reduction for larger adenomas.
Researchers at Penn School of Medicine have developed a targeted therapy combination that overcomes treatment resistance in liver cancer by combining sorafenib with the TRAIL pathway. This combination restores sensitivity to cell death and kills cancer cells, offering new hope for patients.
A study found that MRI examinations before surgical treatment changed the treatment plan in 28% of cases, with 15 patients opting for mastectomy. The delay caused by MRI screenings also increased treatment time by 14 days on average.
Researchers at the University of Pennsylvania School of Medicine have discovered that Notch signaling is not universally essential for maintaining stem cells in bone marrow. This finding opens up new possibilities for developing effective leukemia therapies without harming normal bone marrow.
A recent study suggests that depression care management can improve survival rates in older cancer patients. The research found that comorbid depression shortens survival time with cancer, but intervention with medication and psychotherapy can extend life among cancer patients.
The Lombardi Comprehensive Cancer Center has published a new manual for childhood cancer survivors, providing information on late effects and promoting shared care. The manual aims to ease the transition from active treatment to follow-up care and address psychosocial needs.
Patients with breast cancer who developed anemia during chemotherapy had a significantly higher risk of local recurrence compared to those without anemia. Anemia was defined as a serum hemoglobin level below 12 g/dL during chemotherapy, and occurred in 18.2% of patients receiving CMF chemotherapy.
Biotech companies are developing novel biomarkers to improve cancer diagnostic tests, potentially reducing treatment costs. Researchers at various institutions, including the Ludwig Institute for Cancer Research and Wayne State University School of Medicine, are working on early detection tools for malignancies.
A new breed of targeted cancer drugs is attacking specific proteins in cancer cells, but also causes devastating dermatologic side effects. The Cancer Skin Care Program at Northwestern University provides specially formulated lotions and drugs to help patients preserve their dignity and quality of life.
Recent data from the National Oncologic PET Registry (NOPR) shows that PET scans can dramatically change treatment plans for cancer patients, with a 36.5% change in treatment or no-treatment decisions reported.
Recruitment of pediatric cancer patients into clinical trials is challenging due to age-specific barriers. The article emphasizes the need for more research and international cooperation to improve trial participation, particularly among young people.
The use of sentinel lymph node biopsy (SLNB) increased substantially from 1998 to 2005, but disparities persist in access to the procedure. Non-white women, older women, and those living in poorer areas were less likely to receive SLNB than their counterparts, highlighting uneven access to this less-invasive breast cancer staging test.
A multi-center study found that prostate size and urinary symptoms influence patient satisfaction with cancer treatment. Men with larger prostates may experience improved urination after surgery, while African-American men tend to be less satisfied despite receiving similar care.
Researchers found that only about 45% of cases used tumor markers AFP and HCG, with all three markers measured in just 16% of the time. This suggests low usage rates despite the importance of tumor markers in showing patient response to treatment and disease recurrence.
Zur Hausen demonstrated the role of human papillomavirus in cervical cancer, providing key findings that led to the recognition of HPV as a primary cause. His research also linked HPV to other cancers, including laryngeal carcinoma and penile carcinoma.
Researchers found that surgery combined with heated Intraperitoneal Hyperthermic Chemotherapy (IPHC) improves survival rates for patients with peritoneal carcinoma originating from colorectal or appendix cancer. The study also showed that IPHC may have some benefit in select patients with peritoneal carcinoma and hepatic metastases.
Routine diagnostic approaches for bile duct cancer are only moderately sensitive, with a combination of brush cytology and forceps biopsy yielding only a minor increase in sensitivity. The study highlights the need for additional diagnostic techniques to improve detection rates.
Scientists have discovered specific methylation patterns in tumors and tissue that can predict which lung cancers are more likely to recur. These patterns could lead to reclassifying small lung cancers as advanced disease, allowing for more aggressive treatment options.
A randomized clinical trial found that postoperative chemotherapy does not improve survival in patients with localized gastric cancer. Despite promising results in advanced gastric cancer, the combination of cisplatin, epirubicin, and other chemotherapies did not show significant benefits.
A new study reveals that patients with kidney cancer often receive less optimal surgical care based on the surgeon's practice style rather than medical factors. The study found significant variation in surgeons' preferences for partial nephrectomy and laparoscopic surgery, despite their benefits.
Jeffrey A. Toretsky, a pediatric oncology physician and researcher at Georgetown University's Lombardi Comprehensive Cancer Center, has received a prestigious Clinical Scientist Award in Translational Research from the Burroughs Wellcome Fund. The award will support his research to identify molecular mechanisms of EWS-FLI1 and develop ...
Researchers at Memorial Sloan-Kettering Cancer Center have discovered a new genetic marker that increases breast cancer risk by 1.4 times in women with the DNA variation. The study used genome-wide association mapping to identify a gene locus on chromosome 6 associated with breast cancer risk.